Stay updated on GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial

Sign up to get notified when there's something new on the GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The date has been updated from May 13, 2025, to June 8, 2025.
    Difference
    0.6%
    Check dated 2025-06-12T15:24:35.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    The web page has been updated from version v2.16.1 to v2.16.2.
    Difference
    0.3%
    Check dated 2025-06-05T08:49:45.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.
    Difference
    6%
    Check dated 2025-05-29T05:48:23.000Z thumbnail image
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    The date has been updated from April 15, 2025, to May 13, 2025.
    Difference
    0.6%
    Check dated 2025-05-14T20:34:02.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.3%
    Check dated 2025-04-30T13:51:56.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    The web page has been updated to reflect a new version release, moving from v2.14.4 to v2.15.0, and the date has changed from March 18, 2025, to April 15, 2025.
    Difference
    2%
    Check dated 2025-04-16T01:44:21.000Z thumbnail image

Stay in the know with updates to GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GDC-6036 in KRAS G12C+ Solid Tumors Clinical Trial page.